SILO
SILO
NASDAQ · Biotechnology

Silo Pharma Inc

$6.19
+0.15 (+2.40%)
Financial Highlights (FY 2026)
Revenue
9.7K
Net Income
-571,625
Gross Margin
38.6%
Profit Margin
-5,863.7%
Rev Growth
+1.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.6% 38.6% 63.9% 63.9%
Operating Margin -5,992.5% -5,393.5% 18.2% 20.0%
Profit Margin -5,863.7% -5,570.5% 17.8% 16.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.7K 9.7K 653.1K 554.3K
Gross Profit 3.8K 3.7K 417.2K 354.1K
Operating Income -584,027 -520,471 118.9K 110.9K
Net Income -571,625 -509,419 116.0K 91.5K
Gross Margin 38.6% 38.6% 63.9% 63.9%
Operating Margin -5,992.5% -5,393.5% 18.2% 20.0%
Profit Margin -5,863.7% -5,570.5% 17.8% 16.5%
Rev Growth +1.0% +1.0% -9.1% -7.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 583.1K 550.9K
Total Equity 1.94M 1.85M
D/E Ratio 0.30 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -584,091 -549,446 172.6K 151.1K
Free Cash Flow 101.3K 71.5K